258 related articles for article (PubMed ID: 30962159)
1. Long-term effects of postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia: Balancing the risks and benefits.
Cheong JLY; Doyle LW
Semin Fetal Neonatal Med; 2019 Jun; 24(3):197-201. PubMed ID: 30962159
[TBL] [Abstract][Full Text] [Related]
2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
3. Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
Doyle LW
Neonatology; 2021; 118(2):244-251. PubMed ID: 33975319
[TBL] [Abstract][Full Text] [Related]
4. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.
Bassler D; van den Anker J
Pediatr Clin North Am; 2017 Dec; 64(6):1355-1367. PubMed ID: 29173790
[TBL] [Abstract][Full Text] [Related]
5. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?
Doyle LW; Cheong JLY
Semin Fetal Neonatal Med; 2017 Oct; 22(5):290-295. PubMed ID: 28734731
[TBL] [Abstract][Full Text] [Related]
6. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
[TBL] [Abstract][Full Text] [Related]
7. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
Trials; 2023 May; 24(1):320. PubMed ID: 37161488
[TBL] [Abstract][Full Text] [Related]
8. [Glucocorticoide therapy in premature infants: French practices in 2006].
Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
[TBL] [Abstract][Full Text] [Related]
9. Current Concepts of Corticosteroids Use for the Prevention of Bronchopulmonary Dysplasia.
Perrone S; Orlando S; Petrolini C; Marinelli F; Moretti S; Corradi M; Giordano M; De Bernardo G
Curr Pediatr Rev; 2023; 19(3):276-284. PubMed ID: 36043724
[TBL] [Abstract][Full Text] [Related]
10. Postnatal Corticosteroids To Prevent Bronchopulmonary Dysplasia.
Jensen EA; Watterberg KL
Neoreviews; 2023 Nov; 24(11):e691-e703. PubMed ID: 37907402
[TBL] [Abstract][Full Text] [Related]
11. Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
Filippone M; Nardo D; Bonadies L; Salvadori S; Baraldi E
Am J Perinatol; 2019 Jul; 36(S 02):S58-S62. PubMed ID: 31238361
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis.
Zeng L; Tian J; Song F; Li W; Jiang L; Gui G; Zhang Y; Ge L; Shi J; Sun X; Mu D; Zhang L
Arch Dis Child Fetal Neonatal Ed; 2018 Nov; 103(6):F506-F511. PubMed ID: 29475879
[TBL] [Abstract][Full Text] [Related]
13. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review.
Doyle LW; Ehrenkranz RA; Halliday HL
Neonatology; 2010; 98(3):217-24. PubMed ID: 20389126
[TBL] [Abstract][Full Text] [Related]
15. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.
Ramaswamy VV; Bandyopadhyay T; Nanda D; Bandiya P; Ahmed J; Garg A; Roehr CC; Nangia S
JAMA Pediatr; 2021 Jun; 175(6):e206826. PubMed ID: 33720274
[TBL] [Abstract][Full Text] [Related]
17. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review.
Doyle LW; Ehrenkranz RA; Halliday HL
Neonatology; 2010; 98(2):111-7. PubMed ID: 20150750
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
Szabó H; Baraldi E; Colin AA
Pediatr Pulmonol; 2022 Apr; 57(4):787-795. PubMed ID: 34964564
[TBL] [Abstract][Full Text] [Related]
19. Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.
Zhang ZQ; Zhong Y; Huang XM; Du LZ
BMC Pulm Med; 2017 Dec; 17(1):207. PubMed ID: 29246209
[TBL] [Abstract][Full Text] [Related]
20. Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial.
He Y; Zhang Y; Gao S; Wang X; He N; Zhang D; Dong W; Wieg C; Lei X
Trials; 2020 Sep; 21(1):762. PubMed ID: 32883333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
